Order Article Reprints

Uwamino Y, Yokoyama T, Sato Y, Tanaka S, Kamoshita Y, Shibata A, Kurafuji T, Tanabe A, Arai T, Ohno A, et al. Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots. Vaccines. 2025; 13(7):751. https://doi.org/10.3390/vaccines13070751

Uwamino, Yoshifumi, Takashi Yokoyama, Yasunori Sato, Shiho Tanaka, Yuka Kamoshita, Ayako Shibata, Toshinobu Kurafuji, Akiko Tanabe, Tomoko Arai, Akemi Ohno, and et al. 2025. "Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots" Vaccines 13, no. 7: 751. https://doi.org/10.3390/vaccines13070751

Uwamino, Y., Yokoyama, T., Sato, Y., Tanaka, S., Kamoshita, Y., Shibata, A., Kurafuji, T., Tanabe, A., Arai, T., Ohno, A., Namkoong, H., Nishimura, T., Wakui, M., Murata, M., Hasegawa, N., & Matsushita, H. (2025). Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots. Vaccines, 13(7), 751. https://doi.org/10.3390/vaccines13070751